查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2049599

寡核苷酸合成市場報告：按產品、應用、最終用途和地區分類（2026-2034 年）

Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年全球寡核苷酸合成市場規模達37億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以9.72%的複合年成長率成長，到2034年達到87億美元。推動市場成長的主要因素包括：遺傳性疾病在一般人群中的盛行率不斷上升、新型治療策略的開發以及使用小干擾RNA（siRNA）和反義寡核苷酸治療方法的廣泛應用。

寡核苷酸合成是指依照預定序列建構稱為寡核苷酸的短DNA或RNA分子的過程。它們的長度從幾個鹼基到大約200個鹼基不等。該過程通常在受控的實驗室環境中，利用固相亞磷醯胺化學方法進行。在這個方法中，核苷酸被依序添加到不斷延伸的鏈上，每次添加都伴隨著一系列化學反應。這項技術使科學家能夠生產用於各種應用的客製化寡核苷酸，包括基因合成、聚合酵素鏈鎖反應（PCR）、基因編輯工具（例如CRISPR-Cas9）以及分子診斷測試。寡核苷酸合成技術的進步極大地加速了基因組學和分子生物學研究，並為醫學和生物學研究領域的許多突破性成就提供了支持。

遺傳性疾病在人群中日益普遍是推動全球市場發展的主要動力。這促使人們開發新的治療策略，而基於寡核苷酸的治療方法在其中發揮著至關重要的作用。例如，利用小干擾RNA (siRNA) 和反義寡核苷酸的療法正在被研究並應用於Duchenne氏肌肉失養症和脊髓性肌肉萎縮症等遺傳性疾病的治療。因此，遺傳性疾病盛行率的上升正在推動全球需求。此外，生物資訊學和資料科學的進步也直接影響寡核苷酸治療方法產業。分析大規模基因組資料集能力的提升也對市場產生了正面影響。因此，運算能力的增強正在推動對新型寡核苷酸合成需求的成長。此外，寡核苷酸，特別是反義寡核苷酸，已證明其作為表觀遺傳學研究和治療工具的有效性，有助於基因表現的調控，並提振了市場前景。

寡核苷酸合成市場的趨勢與促進因素：

醫療和製藥業的需求不斷成長

隨著全球對個人化醫療和療法的需求快速成長，寡核苷酸合成市場正以前所未有的速度擴張。這些合成序列是開發針對多種遺傳疾病（包括癌症）的標靶治療的關鍵組成部分。此外，治療性寡核苷酸（如反義寡核苷酸、適配體、siRNA 和免疫刺激性寡核苷酸）的進步，正透過特異性抑製或修飾基因基因表現，徹底改變疾病治療。而且，客製化寡核苷酸的合成是疫苗生產的基礎，包括已證實有效並廣泛應用的基於 mRNA 的 COVID-19 疫苗。隨著製藥公司和研究人員不斷發現寡核苷酸在疾病治療和預防方面的新應用，預計對寡核苷酸合成的需求將進一步成長。

技術進步與創新

寡核苷酸合成技術的穩定發展和改進正在推動市場成長。此外，合成製程的創新，包括高通量和自動化合成系統，提高了寡核苷酸生產的效率、準確性和擴充性。同時，生物資訊學和合成生物學的進步，例如DNA定序和基因編輯（如CRISPR-Cas9），都高度依賴精確合成寡核苷酸的能力。這些進步使得建構更複雜、更多樣化的客製化序列成為可能，促進了合成生物學中原型測試的快速進行，從而推動了更有效率的研發。這種持續的技術進步和發展也為市場做出了貢獻。

擴大合作與夥伴關係

製藥公司、生技公司和研究機構之間的合作與夥伴關係是推動寡核苷酸療法在遺傳疾病治療領域開發和商業化的關鍵驅動力。這些合作匯集了多元化的專業知識、資源和資金，創造出協同增效的環境，能夠迅速將科學發現轉化為實用有效的治療方法。製藥公司為這種合作提供了至關重要的專業知識，充分利用其在藥物開發、臨床試驗和監管流程方面的經驗。它們擁有必要的基礎設施、知識和資源，能夠應對藥物開發的複雜性，並確保寡核苷酸療法符合安全性和有效性的監管標準。它們的參與有助於利用現有的網路、生產能力和分銷管道，簡化商業化進程。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球寡核苷酸合成市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 合成寡核苷酸產品
  • 試劑
  • 裝置
  • 服務

第7章 市場區隔：依應用領域分類

  • PCR引子
  • PCR檢測與試劑盒
  • 順序
  • DNA微陣列
  • 基於螢光的雜合反應（FISH）
  • 反義寡核苷酸
  • 其他

第8章 市場區隔：依最終用途分類

  • 製藥和生物技術公司
  • 醫院/診斷檢查室
  • 學術研究機構

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies Inc.
    • Biolegio BV
    • Bio-Synthesis Inc
    • Eurofins Genomics
    • GenScript
    • Horizon Discovery Ltd
    • Integrated DNA Technologies Inc（Danaher Corporation）
    • Kaneka Eurogentec SA（Kaneka Corporation）
    • LGC Limited
    • Nitto Denko Avecia Inc（Nitto Denko Corporation）
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A3812

The global oligonucleotide synthesis market size reached USD 3.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2034, exhibiting a growth rate (CAGR) of 9.72% during 2026-2034. The growing prevalence of genetic diseases among the masses, the development of novel therapeutic strategies, and the widespread adoption of therapies using small interfering RNAs (siRNAs), and antisense oligonucleotides are some of the major factors propelling the market.

Oligonucleotide synthesis refers to the process of constructing short DNA or RNA molecules, called oligonucleotides, in a predetermined sequence. These can range from just a few bases to around 200 nucleotides in length. The process is accomplished chemically in a controlled laboratory environment, typically using solid phase phosphoramidite chemistry. In this method, nucleotides are sequentially added to a growing chain, each addition involving a series of chemical reactions. This technology enables scientists to generate custom-made oligonucleotides for various applications including gene synthesis, polymerase chain reaction (PCR), gene editing tools, such as CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have dramatically accelerated research in genomics and molecular biology, underpinning many breakthroughs in medical and biological research.

The rising prevalence of genetic diseases among the masses majorly drives the global market. This necessitates the development of novel therapeutic strategies, where oligonucleotide-based therapies play a significant role. For instance, therapies using small interfering RNAs (siRNAs) and antisense oligonucleotides are being investigated and utilized in the treatment of genetic disorders, such as Duchenne muscular dystrophy and spinal muscular atrophy. As such, the growing prevalence of genetic diseases drives the demand on the global level. Along with this, the growth of bioinformatics and data science has a direct impact on the oligonucleotide synthesis industry. The escalating capacity to analyze large genomic datasets is also positively influencing the market. Therefore, the rising computational capability is driving an increased demand for the synthesis of novel oligonucleotides. Furthermore, oligonucleotides particularly antisense oligonucleotides, have been shown to be effective tools in epigenetic research and therapy, helping to modulate gene expression, which is creating a positive market outlook.

OLIGONUCLEOTIDE SYNTHESIS MARKET TRENDS/DRIVERS:

Rising Demand in the Healthcare and Pharmaceutical Industries

The global demand for personalized medicine and therapeutics is rapidly increasing, leading to an unprecedented expansion in the oligonucleotide synthesis market. These synthesized sequences are integral components in developing targeted therapies for various genetic disorders and diseases, including cancer. Along with this, the advancement of therapeutic oligonucleotides, such as antisense oligonucleotides, aptamers, siRNAs, and immunostimulatory oligonucleotides, is revolutionizing disease treatment by specifically inhibiting or altering gene expression. Furthermore, the synthesis of custom oligonucleotides is fundamental to the production of vaccines, including mRNA-based COVID-19 vaccines, which have proven effective and are now widely used. As pharmaceutical companies and researchers continue to discover novel applications for oligonucleotides in the treatment and prevention of diseases, the demand for oligonucleotide synthesis is poised to rise.

Technological Advancements and Innovation

The steady development and refinement of oligonucleotide synthesis technologies are driving market growth. In addition, innovations in the synthesis process, including high-throughput and automated synthesis systems, have increased the efficiency, accuracy, and scalability of oligonucleotide production. Moreover, developments in bioinformatics and synthetic biology , including DNA sequencing and gene editing (e.g., CRISPR-Cas9), heavily rely on the ability to synthesize oligonucleotides accurately. These advancements allow for the creation of custom sequences with greater complexity and diversity and facilitate rapid prototype testing in synthetic biology, thereby fostering more efficient research and development. These continuous technological advancements and developments are also contributing to the market.

Growing Collaborations and Partnerships

Collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become essential drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborations bring together diverse expertise, resources, and funding, creating a synergistic environment that accelerates the translation of scientific discoveries into practical and effective treatments. Pharmaceutical companies, with their experience in drug development, clinical trials, and regulatory processes, contribute vital expertise to the collaboration. They have the infrastructure, knowledge, and resources necessary to navigate the complex landscape of drug development and ensure that oligonucleotide therapies meet regulatory standards for safety and efficacy. Their involvement helps streamline the path to commercialization by leveraging existing networks, manufacturing capabilities, and distribution channels.

OLIGONUCLEOTIDE SYNTHESIS INDUSTRY SEGMENTATION:

Breakup by Product:

  • Synthesized Oligonucleotide Products
  • Reagents
  • Equipment
  • Services

Synthesized oligonucleotide products dominate the market

The market for synthesized oligonucleotide products in the oligonucleotide synthesis industry is being driven by the ever-increasing demand from pharmaceutical and biotechnological companies for drug discovery and development, especially for personalized medicine and targeted therapeutics. Along with this, the rise in genomics and molecular research, fueled by significant advancements in technologies such as Next Generation Sequencing (NGS) and CRISPR gene-editing, is enhancing the requirement for synthesized oligonucleotides. Additionally, the growth in diagnostic applications of oligonucleotides, such as in PCR and microarray assays for genetic and infectious diseases, is propelling the market forward. The expanding field of epigenetics also represents a key driver, with oligonucleotides playing a crucial role in gene expression studies. Moreover, the increasing prevalence of genetic disorders and the resultant demand for novel therapeutic strategies involving oligonucleotides further accelerates the market growth for synthesized oligonucleotide products.

Breakup by Application:

  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In-Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Others

PCR primers dominate the market

The demand for PCR primers in the oligonucleotide synthesis industry is driven by the ongoing global health crisis necessitating extensive viral testing, in which PCR is a primary method. Furthermore, the increasing application of PCR in medical diagnostics, forensics, and research to detect genetic mutations and infectious diseases fuels the demand for primers. In the field of genomics and molecular biology, PCR is considered a crucial tool for DNA sequencing, cloning, and genetic manipulation, and this broad utilization further drives the need for PCR primer synthesis. Apart from this, technological advancements in PCR techniques, such as real-time PCR and digital PCR, are also playing a role in boosting demand. Moreoevr, the growing funding for research in healthcare and life sciences has resulted in expanded use of PCR, thus driving the demand for PCR primers in the overall industry.

Breakup by End Use:

  • Pharmaceutical and Biotechnology Companies
  • Hospital and Diagnostic Laboratories
  • Academic Research Institutes

Academic research institutes dominate the market

The demand for oligonucleotide synthesis in academic research institutes is driven by a rise in genomics and molecular biology research, particularly studies related to gene expression, genetic disorders, and the development of novel therapeutic strategies. Additionally, advancements in technologies such as Next-Generation Sequencing (NGS) and CRISPR gene-editing, which rely on synthesized oligonucleotides, are stimulating demand. In addition, the rising trend of interdisciplinary studies involving bioinformatics and data science, which necessitate the use of oligonucleotides for data validation, further drives the need. Governmental and institutional funding for genomics and biotechnology research is another major driver, enabling academic institutes to invest in oligonucleotide synthesis for various projects. Academic research institutes, with their focus on fundamental research and discovery, often possess cutting-edge knowledge and innovative ideas. By partnering with industry, they can translate their scientific findings into practical applications and commercial products.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest oligonucleotide synthesis market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North American market for oligonucleotide synthesis is propelled by a robust pharmaceutical and biotech industry, with a strong focus on drug discovery and development. The region's emphasis on personalized medicine and targeted therapies further propels this need. Additionally, North America's sophisticated healthcare system with advanced diagnostic capabilities increases the demand for oligonucleotides in diagnostic assays. The region also hosts numerous top-tier academic and research institutes conducting extensive genomics and molecular biology research, which necessitates oligonucleotide synthesis. Moreover, strong governmental and private sector investment in healthcare and life sciences research, particularly in genomics and personalized medicine, fuels the growth of industry in North America. Moreover, the advancements in delivery systems and formulations for oligonucleotide-based therapeutics in North America demonstrate the region's commitment to pushing the boundaries of innovation in this field. These developments not only contribute to the growth of the market but also have the potential to revolutionize the treatment of various diseases, including genetic disorders, cancers, and rare diseases.

COMPETITIVE LANDSCAPE:

The global oligonucleotide synthesis market is experiencing significant growth due to the escalating investments in the development of new production facilities, upgrading existing ones, and implementing more efficient production processes. Therefore, Companies are heavily investing in research and development to innovate their offerings, including developing new synthesis techniques, improving the scale and accuracy of synthesis, and creating new types of oligonucleotide products to support various applications in diagnostics, therapeutics, and research. Along with this, companies are entering into strategic collaborations, partnerships, and acquisitions to co-develop oligonucleotide-based drugs, share technology and expertise, or expand into new markets. In addition, the introduction of therapeutics, such as antisense oligonucleotides, siRNAs, and miRNAs, offer new avenues for treating a wide range of diseases, including genetic disorders and cancers is positively influencing the market. Furthermore, key players are offering services for the custom synthesis of oligonucleotides. This allows researchers and developers to order specific oligonucleotide sequences tailored to their needs, which is particularly important in fields like genomics, molecular biology, and personalized medicine.

The report has provided a comprehensive analysis of the competitive landscape in the global oligonucleotide synthesis market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Biolegio B.V.
  • Bio-Synthesis Inc
  • Eurofins Genomics
  • GenScript
  • Horizon Discovery Ltd
  • Integrated DNA Technologies Inc (Danaher Corporation)
  • Kaneka Eurogentec S.A. (Kaneka Corporation)
  • LGC Limited
  • Nitto Denko Avecia Inc (Nitto Denko Corporation)
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global oligonucleotide synthesis market in 2025?
  • 2.What is the expected growth rate of the global oligonucleotide synthesis market during 2026-2034?
  • 3.What are the key factors driving the global oligonucleotide synthesis market?
  • 4.What has been the impact of COVID-19 on the global oligonucleotide synthesis market?
  • 5.What is the breakup of the global oligonucleotide synthesis market based on the product?
  • 6.What is the breakup of the global oligonucleotide synthesis market based on the application?
  • 7.What is the breakup of the global oligonucleotide synthesis market based on end use?
  • 8.What are the key regions in the global oligonucleotide synthesis market?
  • 9.Who are the key players/companies in the global oligonucleotide synthesis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oligonucleotide Synthesis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Synthesized Oligonucleotide Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Equipment
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 PCR Primers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Assays and Panels
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Microarrays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fluorescence In-Situ Hybridization (FISH)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Antisense Oligonucleotides
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital and Diagnostic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biolegio B.V.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Synthesis Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eurofins Genomics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 GenScript
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Horizon Discovery Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Integrated DNA Technologies Inc (Danaher Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Kaneka Eurogentec S.A. (Kaneka Corporation)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 LGC Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nitto Denko Avecia Inc (Nitto Denko Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oligonucleotide Synthesis Market: Major Drivers and Challenges
  • Figure 2: Global: Oligonucleotide Synthesis Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Oligonucleotide Synthesis Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Oligonucleotide Synthesis Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Oligonucleotide Synthesis Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Oligonucleotide Synthesis Market: Breakup by End Use (in %), 2025
  • Figure 7: Global: Oligonucleotide Synthesis Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Oligonucleotide Synthesis (Synthesized Oligonucleotide Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Oligonucleotide Synthesis (Synthesized Oligonucleotide Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Oligonucleotide Synthesis (Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Oligonucleotide Synthesis (Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Oligonucleotide Synthesis (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Oligonucleotide Synthesis (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Oligonucleotide Synthesis (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Oligonucleotide Synthesis (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Oligonucleotide Synthesis (PCR Primers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Oligonucleotide Synthesis (PCR Primers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Oligonucleotide Synthesis (PCR Assays and Panels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Oligonucleotide Synthesis (PCR Assays and Panels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Oligonucleotide Synthesis (Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Oligonucleotide Synthesis (Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Oligonucleotide Synthesis (DNA Microarrays) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Oligonucleotide Synthesis (DNA Microarrays) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Oligonucleotide Synthesis (Fluorescence In-Situ Hybridization (FISH)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Oligonucleotide Synthesis (Fluorescence In-Situ Hybridization (FISH)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Oligonucleotide Synthesis (Antisense Oligonucleotides) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Oligonucleotide Synthesis (Antisense Oligonucleotides) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Oligonucleotide Synthesis (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Oligonucleotide Synthesis (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Oligonucleotide Synthesis (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Oligonucleotide Synthesis (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Oligonucleotide Synthesis (Hospital and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Oligonucleotide Synthesis (Hospital and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Oligonucleotide Synthesis (Academic Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Oligonucleotide Synthesis (Academic Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: United States: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: United States: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Canada: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Canada: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Asia-Pacific: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Asia-Pacific: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: China: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: China: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Japan: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Japan: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: India: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: India: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: South Korea: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: South Korea: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Australia: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Australia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Indonesia: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Indonesia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Others: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Europe: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Europe: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Germany: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Germany: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: France: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: France: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: United Kingdom: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: United Kingdom: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Italy: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Italy: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Spain: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Spain: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Russia: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Russia: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Middle East and Africa: Oligonucleotide Synthesis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Middle East and Africa: Oligonucleotide Synthesis Market: Breakup by Country (in %), 2025
  • Figure 84: Middle East and Africa: Oligonucleotide Synthesis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Global: Oligonucleotide Synthesis Industry: SWOT Analysis
  • Figure 86: Global: Oligonucleotide Synthesis Industry: Value Chain Analysis
  • Figure 87: Global: Oligonucleotide Synthesis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oligonucleotide Synthesis Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Oligonucleotide Synthesis Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Oligonucleotide Synthesis Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Oligonucleotide Synthesis Market: Competitive Structure
  • Table 7: Global: Oligonucleotide Synthesis Market: Key Players